Histopathological investigations confirmed that the tumor was HBL with common characteristics and immunostaining of inhibin alpha [29], and endothelial cell markers, CD31, CD34, and CD56 [30], also confirmed the present case as HBL. This evidence concerns the gene INHA and neoplasm.